There’s gouda news for cheese lovers. A recent study found cheese eaters are less likely to have sleep apnea than their dairy ...

Researchers have discovered why the lungs are often targeted by metastasizing cancer cells, pinpointing the amino acid ...

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

Endoscopic sleeve gastroplasty proved effective as a standalone procedure, improving obesity-related comorbidities and ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

The updated prescribing information states that hepatotoxicity has occurred in the postmarketing setting and encourages hepatic laboratory tests -- including serum alanine transaminase, aspartate ...

Levels of serum muscle enzymes such as creatine kinase (CK), lactate dehydrogenase (LDH), asparate aminotransferase (AST) and alanine aminotransferase (ALT) are usually elevated. However, high levels ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

Fatty liver disease, affecting nearly 30% of the global population, is a growing public health concern. It occurs when fat accumulates excessively in liver cells, impairing their ability to function.

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA slapped a boxed warning on fezolinetant (Veozah), a ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...